| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date | Match? |
|---|
| FXIII-A Leu34 genetic variant in premature coronary artery disease: a genotype--phenotype case control study | [1]Johanne Silvain, [2]Ana Pena, [3]Jean-Baptiste Vignalou, [4]Jean-Sébastien Hulot, [5]Sophie Galier, [6]Guillaume Cayla, [7]Anne Bellemain-Appaix, [8]Olivier Barthélémy, [9]Farzin Beygui, [10]Claire Bal-dit-Sollier, [11]Ludovic Drouet, [12]John W Weisel, [13]Gilles Montalescot, [14]Jean-Phillippe Collet [Full author list] | Thrombosis and Haemostasis [missing] | DOI: 10.1160/TH11-01-0027 [ORCID]
PubMed: 21800001 [ORCID]
| coronary artery disease [missing] | 2011-09-01 | |
| High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2). | [1]Jean-Philippe Collet, [2]Jean-Sébastien Hulot, [3]Ghalia Anzaha, [4]Ana Pena, [5]Thomas Chastre, [6]Claire Caron, [7]Johanne Silvain, [8]Guillaume Cayla, [9]Anne Bellemain-Appaix, [10]Jean-Baptiste Vignalou, [11]Sophie Galier, [12]Olivier Barthélémy, [13]Farzin Beygui, [14]Vanessa Gallois, [15]Gilles Montalescot, [16]CLOVIS-2 Investigators [Full author list] | JACC: Cardiovascular Interventions [missing] | DOI: 10.1016/J.JCIN.2011.03.002 [ORCID]
PubMed: 21511218 [ORCID]
| clopidogrel [missing] | 2011-04-01 | |
| Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis | [1]Yacine Boulaftali, [2]Benoit Ho-Tin-Noe, [3]Ana Pena, [4]Stéphane Loyau, [5]Laurence Venisse, [6]Déborah François, [7]Benjamin Richard, [8]Véronique Arocas, [9]Jean-Philippe Collet, [10]Martine Jandrot-Perrus, [11]Marie-Christine Bouton [Full author list] | Circulation [missing] | DOI: 10.1161/CIRCULATIONAHA.110.000885 [ORCID]
PubMed: 21403095 [ORCID]
| thrombolysis [missing] | 2011-03-14 | |
| Composition of coronary thrombus in acute myocardial infarction | [1]Johanne Silvain, [2]Jean-Philippe Collet, [3]Chandrasekaran Nagaswami, [4]Farzin Beygui, [5]Kathryn E Edmondson, [6]Anne Bellemain-Appaix, [7]Guillaume Cayla, [8]Ana Pena, [9]Delphine Brugier, [10]Olivier Barthelemy, [11]Gilles Montalescot, [12]John W Weisel [Full author list] | Journal of the American College of Cardiology [missing] | DOI: 10.1016/J.JACC.2010.09.077 [ORCID]
PubMed: 21414532 [ORCID]
| myocardial infarction [missing] | 2011-03-01 | |
| New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis | [1]Anne Bellemain-Appaix, [2]David Brieger, [3]Farzin Beygui, [4]Johanne Silvain, [5]Ana Pena, [6]Guillaume Cayla, [7]Olivier Barthélémy, [8]Jean-Philippe Collet, [9]Gilles Montalescot [Full author list] | Journal of the American College of Cardiology [missing] | DOI: 10.1016/J.JACC.2010.07.012 [ORCID]
PubMed: 20800407 [ORCID]
| clopidogrel [missing]; meta-analysis [missing] | 2010-08-26 | |
| Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates | [1]Farzin Beygui, [2]Johanne Silvain, [3]Ana Pena, [4]Anne Bellemain-Appaix, [5]Jean-Philippe Collet, [6]Helmut Drexler, [7]Deepak Bhatt, [8]Eric Vicaut, [9]Gilles Montalescot [Full author list] | American Journal of Cardiology [missing] | DOI: 10.1016/J.AMJCARD.2010.04.019 [ORCID]
PubMed: 20723640 [ORCID]
| acute coronary syndrome [missing]; biomarker [missing] | 2010-07-23 | |
| Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis | [1]Jean-Sébastien Hulot, [2]Jean-Philippe Collet, [3]Johanne Silvain, [4]Ana Pena, [5]Anne Bellemain-Appaix, [6]Olivier Barthélémy, [7]Guillaume Cayla, [8]Farzin Beygui, [9]Gilles Montalescot [Full author list] | Journal of the American College of Cardiology [missing] | DOI: 10.1016/J.JACC.2009.12.071 [ORCID]
PubMed: 20620727 [ORCID]
| circulatory system [missing]; clopidogrel [missing]; meta-analysis [missing] | 2010-07-01 | |
| Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION study | [1]Johanne Silvain, [2]Ana Pena, [3]Guillaume Cayla, [4]David Brieger, [5]Anne Bellemain-Appaix, [6]Thomas Chastre, [7]Jean-Baptiste Vignalou, [8]Farzin Beygui, [9]Olivier Barthelemy, [10]Jean-Philippe Collet, [11]Gilles Montalescot [Full author list] | European Heart Journal [missing] | DOI: 10.1093/EURHEARTJ/EHQ209 [ORCID]
PubMed: 20591842 [ORCID]
| | 2010-06-29 | |
| Enoxaparin anticoagulation monitoring in the catheterization laboratory using a new bedside test | [1]Johanne Silvain, [2]Farzin Beygui, [3]Annick Ankri, [4]Anne Bellemain-Appaix, [5]Ana Pena, [6]Olivier Barthelemy, [7]Guillaume Cayla, [8]Vanessa Gallois, [9]Sophie Galier, [10]Dominique Costagliola, [11]Jean-Philippe Collet, [12]Gilles Montalescot [Full author list] | Journal of the American College of Cardiology [missing] | DOI: 10.1016/J.JACC.2009.08.077 [ORCID]
PubMed: 20170785 [ORCID]
| catheterization [missing]; anticoagulation [missing] | 2010-02-01 | |
| Can we override clopidogrel resistance? | [1]Ana Pena, [2]Jean-Philippe Collet, [3]Jean-Sébastien Hulot, [4]Johanne Silvain, [5]Olivier Barthélémy, [6]Farzin Beygui, [7]Christian Funck-Brentano, [8]Gilles Montalescot [Full author list] | Circulation [missing] | DOI: 10.1161/CIRCULATIONAHA.108.857722 [ORCID]
PubMed: 19487603 [ORCID]
| clopidogrel [missing] | 2009-06-01 | |
| Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) study | [1]Jean-Philippe Collet, [2]Johanne Silvain, [3]Antoine Landivier, [4]Marie-Laure Tanguy, [5]Guillaume Cayla, [6]Anne Bellemain, [7]Nicolas Vignolles, [8]Sophie Gallier, [9]Farzin Beygui, [10]Ana Pena, [11]Gilles Montalescot [Full author list] | Circulation [missing] | DOI: 10.1161/CIRCULATIONAHA.108.776757 [ORCID]
PubMed: 18765393 [ORCID]
| clopidogrel [missing]; angioplasty [missing] | 2008-09-02 | |